Activity value 76peru Buyer,Last transaction date:
2026-02-03
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for lider pharma s.a. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 6 transactions, with a transaction quantity of 15467 and a transaction weight of 25596.
YearTransactionsQuantityWeight
202537203284.45112999.98
202661546725596
Bill of lading data
<
1/15
>
Trade date
2026/02/03
B/L No.
056106
Suppliers
——
Buyers
lider pharma s.a.
POLs
nhava sheva (jawaharlal nehru)
PODs
marítima del callao
Product description
LEVONORGESTREL 1.5 MG,UNICURE,S/M, POSTTERGA D LEVONORGESTREL TABLETS BP 1.5ML PHARMACEUTICALS DRUGS AND MEDICINES AUTORIZAR CON EL NÚMERO EE-10007
Expand
Trade date
2026/02/03
B/L No.
055702
Suppliers
——
Buyers
lider pharma s.a.
POLs
nhava sheva (jawaharlal nehru)
PODs
marítima del callao
lider pharma s.a. is peru Buyer,
and primarily engages in the import and export business of products such as amoxicillin,voltaren,fer-in-sol.
According to the 52wmb.com global trade database, as of 2026-02-03, the company has completed 119 international trades,
with its main trading regions covering china,india,hong kong etc.
The core products include HS3004902900,HS2941102000,HS3004201900 etc,
often transported via marítima del callao,port callao, port lima etc,
and its main trading partners are jiangsu eyoung medical devices co.,ltd.,yiwu lance imports export ltd.,opko health asiatic limitedunit.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on lider pharma s.a. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.